Table 2 Co-morbidities, clinical conditions and chronic medications (n = 578)
Characteristic | Description | Count | Proportion |
|---|---|---|---|
HIV status | Negative | 95 | 16.4 % |
Positive | 477 | 82.5 % | |
Unknown | 6 | 1.0 % | |
CD4 counta (n = 477) | Low (≤100 cells/mm3) | 173 | 36.3 % |
>100 cells/mm3 | 198 | 41.5 % | |
Missing | 106 | 22.2 % | |
ART status (n = 477) | Not on ART | 116 | 24.3 % |
Median CD4 count | 156.5 | IQR: 65, 255 | |
Initiated ART with or after RR TB | 153 | 32.1 % | |
Median CD4 count | 100.5 | IQR: 42.5, 221.5 | |
Median days RR TB at ART initiation | 26 | IQR: 14, 42 | |
On ART prior to RR TB initiation | 209 | 43.8 % | |
Median CD4 count | 101 | IQR: 41, 253 | |
Median days on ART at RR TB initiation | 332 | IQR: 160, 991 | |
ART regimen (n = 362) | TDF + 3TC or ETC + EFV | 182 | 50.23 % |
D4T or AZT + 3TC + EFV | 34 | 9.4 % | |
TDF + 3TC + LPV/r | 3 | 0.8 % | |
D4T or AZT + 3TC + LPV/r | 46 | 12.7 % | |
Other regimen | 53 | 14.6 % | |
Missing | 44 | 12.2 % | |
Reported co-morbidities | Hepatitis or liver disorder | 7 | 1.2 % |
Epilepsy | 6 | 1.0 % | |
Psychiatric disorder | 5 | 0.9 % | |
Diabetes mellitus | 9 | 1.6 % | |
Renal dysfunction | 8 | 1.4 % | |
Pregnancy (n = 295) | Pregnant | 7 | 2.4 % |
Contraception (n = 295) | Using hormonal contraceptive | 16 | 5.4 % |